Corporate governance is an integral component to the business of BB Biotech AG (the Company). The Board of Directors is committed  to implement corporate governance policies which are aligned with the size and complexity of the Company’s activities.

We ensure transparency for our shareholders by disclosing the articles of incorporation, the organizational regulations as well as the Audit & Risk Committee Charter, the Remuneration and Nomination Committee Charter and the Sustainability and Governance Committee Charter on our homepage. This report is intended to supplement the annual report with respect to corporate governance policies and implementation of these policies in our business. As BB Biotech AG is listed on the Swiss and German stock exchanges, the Company is required to comply with the rules and regulations that apply to each of these markets.

Notification concerning transactions by persons performing managerial responsibilities pursuant to Article 19 MAR

Transaction of BB Biotech AG (ISIN CH0038389992, par value of CHF 0.20), Schwertstrasse 6, CH-8200 Schaffhausen done by the Board of Directors, the Management or close associates of these persons are reported here.